CDNA NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

CareDx Inc · Healthcare · Diagnostics & Research

Open interactive chart View report data
Latest close 37.14 USD
-6.5% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 68.2% above the Trend Line and sits at 88.6% of its 52-week range. The latest completed week returned -6.5%, after a 28.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. Options positioning is volatility with 56/100 conviction, while the latest news-sentiment score is 59/100. Near-term considerations: earnings are due in 5d.

Setup score 66 out of 100
Latest Close 37.14 USD 24 Jul 2026
1W Return -6.5% latest completed week
4W Return 28.9% short-term follow-through
12W Return 72.7% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • The trend backdrop is active with a 15-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 5 reversal markers appear in the recent smart-money tape.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -6.5% Latest completed week; four-week move 28.9%. Indicator stack 77/79 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 56/100 conviction; expected move 19.8%. News sentiment 59/100 59 relevant articles in the latest sentiment read. Event risk 5d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 68.2% above the Trend Line and sits at 88.6% of its 52-week range. The latest completed week returned -6.5%, after a 28.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9712-week average 0.71

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.97Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers55 reversal markers

No recent accumulation markers. 5 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 28.9% over four weeks, 72.7% over 12 weeks, and 190.4% over one year. The current trend has remained active for 15 consecutive weeks.

Performance by holding period

1W-6.5%
4W28.9%
12W72.7%
26W81.9%
52W190.4%
Active trend streak15 weeks
Active weeks in one year30
Trend breadth57.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.56Latest activity-pressure read.
Pressure change17.5%Four-week change in activity pressure.
Leadership79.52Latest relative-leadership reading.
RS change90.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 91% Model confidence 87%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength20/100Blend of value, momentum, and quality. Underlying universe rank 81; rank 1 is best.
Value10/100Relative valuation strength. Underlying universe rank 91; rank 1 is best.
Quality27/100Profitability and accounting quality. Underlying universe rank 74; rank 1 is best.
Momentum97/100Medium-term price momentum. Underlying universe rank 4; rank 1 is best.
Growth78/100Revenue and earnings growth. Underlying universe rank 23; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
4.6x
Market value relative to trailing revenue.
EV / EBITDA
174.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
68.6%
Gross profit retained from each unit of revenue.
Operating margin
-2.4%
Operating profit retained from revenue.
Free-cash-flow margin
19.6%
Free cash flow generated from revenue.
Return on invested capital
-2.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
19.2%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
141.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
4.3%
Net share repurchases relative to market value.
Shareholder yield
4.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-5.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

CDNA shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.22, expected move of 19.8%, and Sharemaestro trend signal active.

Conviction56/100
Expected move19.8%
Put/call volume0.22
Pressure52
Speculation24
Volatility94
Trend agreement74
Open options detail
Insider activity6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment59/100

Weighted news tone is neutral across 59 relevant articles.

26 positive · 31 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings5dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move19.8%Nearest-chain priced movement where available.
52-week drawdown-8.2%Distance below the 52-week high.
13-week volatility11.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+39.4%Week of 17 Jul.
Worst week-12.3%Week of 10 Apr.
Latest week-6.5%Week of 24 Jul.

Shape of recent returns

Strong gains7
Modest gains7
Flat weeks0
Modest losses5
Sharp losses7
Recent vol11.7%13-week weekly-return volatility.
Base vol8.9%52-week weekly-return volatility.
Up/down split32/20Count of positive and negative weeks in the 52-week window.
Average skew6.7% / -4.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape64/100

Trend, activity pressure, participation, and risk combine to a 64/100 tape read.

 Indicator analysis81/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 11/12.

Activity pressure 0.97; 5 reversal markers Factors35/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 14; Small Cap Core rank 90 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options58/100

CDNA shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.22, expected move of 19.8%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 19.8% Sentiment59/100

Weighted news tone is neutral across 59 relevant articles.

CareDx Announces Second Quarter 2026 Financial Results Insiders6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

 Earnings5d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202637.14 USD-6.5%22.08 USD17.27 USD1.5679.524.6MOn
17 Jul 202639.73 USD39.4%21.49 USD17.10 USD1.6092.858.4MOn
10 Jul 202628.51 USD-2.3%20.81 USD16.91 USD1.5435.794.4MOn
3 Jul 202629.19 USD1.3%20.55 USD16.79 USD1.4041.812.7MOn
26 Jun 202628.82 USD10.1%20.19 USD16.67 USD1.3341.815.8MOn
19 Jun 202626.18 USD14.0%19.83 USD16.54 USD1.0723.485.6MOn
12 Jun 202622.97 USD3.2%19.53 USD16.42 USD0.8711.173.5MOn
5 Jun 202622.25 USD-2.5%19.29 USD16.33 USD0.679.914.4MOn
29 May 202622.82 USD5.5%19.07 USD16.23 USD0.557.262.4MOn
22 May 202621.63 USD8.3%18.81 USD16.14 USD0.574.474.0MOn
15 May 202619.97 USD-8.5%18.59 USD16.05 USD0.41-2.582.5MOn
8 May 202621.82 USD1.5%18.40 USD15.97 USD0.575.703.0MOn
1 May 202621.50 USD1.3%18.15 USD15.88 USD0.189.815.1MOn
24 Apr 202621.23 USD-0.9%17.94 USD15.80 USD-0.2210.192.7MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.